Muromonab-Cd3 vs Upadacitinib
Muromonab-Cd3 vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Muromonab-Cd3 and Upadacitinib.
Mechanism of Action
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Upadacitinib β C17H19F3N6O.
Molecular Weight: Upadacitinib β 380.3700 g/mol.
Type: Muromonab-Cd3 β Unknown; Upadacitinib β Small molecule.